Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 512-1 (miR-512-1)
- Target
- miR-512-1
- Molecular classification
- Other (microRNA, non-coding RNA)
01
Overview
microRNA 512-1 (miR-512-1) is a small, non-coding RNA belonging to the microRNA class of gene regulators. It is transcribed as a primary miRNA (pri-miRNA) that is processed into a precursor miRNA (pre-miRNA) and then into the mature miRNA, which is about 20–24 nucleotides long. miR-512-1 regulates gene expression at the post-transcriptional level by binding to target mRNAs and promoting their degradation or inhibiting their translation. Like other microRNAs, it functions as part of the RNA-induced silencing complex (RISC). Associations reported in human disease primarily relate to altered expression patterns in cancers and some other conditions, but it is not a direct therapeutic target (e.g., receptor or enzyme)
- Other names
- hsa-mir-512-1MIRN512-1mir-512-1MIR512-1
02
Mechanism of action
Not applicable (microRNA 512-1 acts as a post-transcriptional regulator rather than as a drug target; no drugs directly act via this molecule)
03
Biological functions
Post-transcriptional regulation of gene expressionRegulation of mRNA stability and translationLikely involvement in cell proliferation, differentiation, and apoptosis (as is typical for microRNAs)
04
Disease associations
Cancer (associated with differential expression in some malignancies, prognostic significance in some tumors)Alcoholic cardiomyopathyAsymptomatic dengue virus infectionOther (microRNAs are widely implicated in various pathologies)
05
Safety considerations
None specifically described for miR-512-1; general challenges for microRNA therapeutics include off-target effects and delivery
06
Interacting drugs
None identified (no small molecule or biologic drugs are known to directly target miR-512-1 at this time)
07
Biomarkers
miRNA panels (including miR-512-1) have been used experimentally for disease classification or prognosis, e.g., in cancer subtyping; specific use as a clinical biomarker for miR-512-1 alone is not established
Beyond the preview
Go deeper on microRNA 512-1 (miR-512-1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on microRNA 512-1 (miR-512-1).